Nucl Med Mol Imaging.
2006 Oct;40(5):275-278.
Discrepancy of Bone Metastases between F-18 FDG PET/CT and Bone Scan in a Patient with Prostate Cancer
- Affiliations
-
- 1Department of Nuclear Medicine, Inha University College of Medicine, Incheon, Korea. iyhyun@inha.ac.kr
- 2Department of Internal Medicine, Inha University College of Medicine, Incheon, Korea.
- 3Department of Radiology, Inha University College of Medicine, Incheon, Korea.
Abstract
-
We report the case of a 73-year-old man who had prostate cancer with bone metastases. Tc-99m HDP Whole body bone scan revealed multiple areas of increased bony uptake consistent with widespread bone metastases. F-18 fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) demonstrated mild F-18 FDG uptake in the lymph nodes of neck, abdomen, and pelvis. However, abnormal F-18 FDG uptake was not seen in the skeletal system. Biopsy and immunohistochemical stains of left supraclavicular mass showed metastatic prostate adenocarcinoma. Currently, there are a few reported cases of F-18 FDG PET/CT evaluation of bone metastases in prostate cancer. We discuss the discrepancy between F-18 FDG PET/CT and bone scan in the detection of osseous metastases of prostate cancer.